Research & Perspectives

  1. pDNA And mRNA Manufacturing In The Age Of Precision Therapies 5/27/2026

    CDMOs play a critical role in scaling pDNA and mRNA manufacturing, enabling precision therapies through flexible capacity, regulatory expertise, and high-quality, cost-efficient production solutions.

  2. Plasmid, mRNA, And Viral Vector Manufacturing 5/27/2026

    Scaling plasmid, mRNA, and viral vector production is key for gene therapies, requiring integrated processes, quality inputs, and advanced capabilities for consistent, reliable supply.

  3. Bispecific Antibodies: Engineering Complexity Into Simplicity 5/27/2026

    Bispecific antibodies deliver dual-target precision but require advanced design to balance stability, manufacturability, and performance for treating complex diseases beyond single-target biologics.

  4. Advancing mAb Manufacturing With Customer-Centric Solutions 5/27/2026

    Customer-centric innovations in monoclonal antibody manufacturing address cost, scalability, and regulatory challenges while improving yield, efficiency, and delivery of complex biologic therapies.

  5. Achieving Manufacturing Milestones Through Systematic Tech Transfer 5/27/2026

    A risk-based approach to tech transfer ensures consistent biologics manufacturing, enabling efficient scale-up, reduced risk, and reliable, right-first-time outcomes across production.

  6. Reducing Variability In Gene Expression: Bottlenecks And Solutions 5/26/2026

    Gene expression variability in biologics comes from random gene integration and cell heterogeneity; advanced engineering and targeted integration improve consistency, stability, and productivity.

  7. Achieving 3-4-Fold Higher Titers Of Monoclonal Antibodies 5/26/2026

    An intensified fed-batch process boosts monoclonal antibody production 3–4× by optimizing cell density, improving efficiency, lowering costs, and maintaining consistent quality.

  8. Cell Line Development: Faster Path To A Stable Master Cell Bank 5/26/2026

    Cell line development builds stable, high-yield cell lines and a master cell bank, enabling consistent, scalable biologics manufacturing through selection, characterization, and cryopreservation.

  9. How Antibody Drug Conjugate Therapies Deliver Precision 5/26/2026

    Antibody drug conjugates target cancer cells with potent payloads, combining precision and cytotoxicity to boost efficacy, reduce toxicity, and tackle complex tumors.

  10. Untapped Potential In Animal Health Innovation 5/26/2026

    Animal health innovation is driving rapid market growth, fueled by rising demand and complexity, creating opportunities for advanced therapies, sustainability, and better disease management.